Department of Propedeutics of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Poland.
Eur J Obstet Gynecol Reprod Biol. 2011 Sep;158(1):37-41. doi: 10.1016/j.ejogrb.2011.04.026. Epub 2011 Jun 12.
In the working hypothesis we assumed that the procoagulant activity of microparticles (MPs) is associated with the concentration of tissue factor (TF) and its inhibitor (TFPI), and that these three components together affect fetal hemostasis. The aim of the study was to check whether MPs are present in the cord blood, to compare their concentration with that in the maternal blood, as well as to measure the concentrations of TF antigen and TFPI antigen in the cord blood and maternal blood.
The study group consisted of 28 healthy parturient women who gave normal delivery, and their 28 babies. Blood from the umbilical vein was collected immediately after delivery, still prior to omphalotomy, whereas mother's blood was obtained from the antecubital vein. The concentration of MPs as well as TF antigen and TFPI antigen were measured using ELISA method.
The level of MPs in cord blood plasma was found to be 6.25 times higher than in the mother's blood plasma (median: 26.76 nM PS; range: 22.90-34.41 nM PS vs. median: 4.26 nM PS; range: 2.68-5.37 nM PS respectively, p=0.0022), whereas the level of TF antigen was 1.94 times higher in the fetus than in the mother (median: 238.03 pg/ml; range: 192.25-283.10 pg/ml vs. median: 122.4 pg/ml, range: 52.71-176.74 pg/ml, respectively, p=0.0012). On the other hand, the level of TFPI antigen was lower in cord blood plasma than in maternal blood plasma, accounting for 33.95% of the value noted in the mother (median: 30.04 ng/ml, range: 24.84-35.12 ng/ml vs. median: 88.48 ng/ml; range: 78.64-107.20 ng/ml, respectively, p<0.0001). There was no correlation between MP concentration and the levels of TF as well as TFPI in fetal blood and maternal blood.
Microparticles (MPs) are constituent components of cord blood plasma; their concentration is significantly higher than that in mother's blood plasma. In the fetus, MPs may play a role of a powerful procoagulant, thus facilitating thrombin generation (TF-dependent thrombin generation, which may take place on their surface); this hypothesis is based on literature data and our own evidence.
在我们的工作假设中,我们假设微粒(MPs)的促凝活性与组织因子(TF)及其抑制剂(TFPI)的浓度有关,并且这三个成分共同影响胎儿的止血功能。本研究的目的是检查脐带血中是否存在 MPs,比较其浓度与母血中的浓度,并测量脐带血和母血中 TF 抗原和 TFPI 抗原的浓度。
研究组由 28 名正常分娩的健康产妇及其 28 名婴儿组成。在分娩后立即从脐静脉采集血液,仍然在脐部切开术之前,而母亲的血液则从前臂静脉采集。使用 ELISA 法测量 MPs 浓度以及 TF 抗原和 TFPI 抗原浓度。
发现脐带血血浆中的 MPs 水平比母血血浆高 6.25 倍(中位数:26.76 nM PS;范围:22.90-34.41 nM PS 与中位数:4.26 nM PS;范围:2.68-5.37 nM PS,p=0.0022),而胎儿 TF 抗原水平比母亲高 1.94 倍(中位数:238.03 pg/ml;范围:192.25-283.10 pg/ml 与中位数:122.4 pg/ml,范围:52.71-176.74 pg/ml,p=0.0012)。另一方面,脐带血血浆中的 TFPI 抗原水平低于母血血浆,占母亲值的 33.95%(中位数:30.04 ng/ml,范围:24.84-35.12 ng/ml 与中位数:88.48 ng/ml;范围:78.64-107.20 ng/ml,p<0.0001)。在胎儿和母亲的血液中,MP 浓度与 TF 和 TFPI 的水平之间没有相关性。
微粒(MPs)是脐带血血浆的组成成分;其浓度明显高于母血血浆。在胎儿中,MPs 可能发挥强大的促凝作用,从而促进凝血酶生成(TF 依赖性凝血酶生成,可能发生在它们的表面);这一假设基于文献数据和我们自己的证据。